Peterson Katharine sold ACRV
August 18, 2026 · Form 4 insider transaction
Peterson Katharine sold 101 shares of Acrivon Therapeutics, Inc. at $2.01 per share, a transaction worth $203.01. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
101
Price
$2.01
Total value
$203.01
InsiderPeterson Katharine
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 18, 2026
Filing dateAugust 20, 2026
Shares owned after18,033
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.